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ABSTRACT
Introduction: The aim of this study was to investigate the effects of a topical 
mucoadhesive formulation with Curcuma longa L. extract (MFC) on oral wound healing. 
Methods: Seventy-two Wistar rats were randomly assigned to 3 groups: Control, 
Vehicle, and MFC. Traumatic ulcers were made on the dorsum of the tongue with a 
3-mm diameter punch. Vehicle and MFC groups received application of the products 
twice a day, while animals in the control group were cared for in identical conditions 
but received no product application. Six rats in each group were euthanized at days 3, 
5, 10, and 14. Percentage of repair was calculated based on wound area. HE-stained 
histological sections were obtained for semi-quantitative analysis of re-epithelization 
and inflammation.
Results: Clinical findings revealed that at days 3 and 5, animals from the MFC group 
exhibited a significantly higher percentage of wound repair. At day 5, animals from 
this group also demonstrated a significant increase in the degree of re-epithelization 
and inflammation.
Conclusions: MFC is capable of accelerating oral wound repair in an in vivo model 
by modulating the inflammatory process and stimulating epithelial proliferation.
Keywords: Curcumin; turmeric extract; curcuminoid; phytotherapy; 
phytomedicine.
INTRODUCTION
Oral ulcers are frequently seen in dental clinic and they may indicate the 
clinical manifestation of several local and systemic conditions. Among the 
most common types, traumatic ulcers and recurrent aphthous stomatitis are 
associated with symptoms such as pain and discomfort1. These lesions usually 
repair over a period of 7 to 10 days through the normal healing process, 
restoring the integrity of the tissue. Treatment protocols for oral ulcers aim 
at accelerating repair and relieving symptomatology, and the use of topical 
corticosteroids, such as dexamethasone and clobetasol, are the most prevalent. 
However, even the topical application of corticosteroids can lead to systemic 
adverse reactions if the drug is absorbed into the bloodstream2. Although in 
most cases the adverse effects are mild, there are reports of patients who 
developed Cushing’s syndrome through the topical use of corticosteroids2,3. 
Thus, equally effective and safer treatment alternatives should be developed.
Natural products (phytotherapeutics) have been shown to be effective 
alternatives in the treatment of inflammatory diseases and induce the repair 
of lesions in different tissues2,4-6. The beneficial effects of herbal medicines 
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have been associated to the biological functions 
of substances such as alkaloids, triterpenes, and 
biomolecules that influence one or more stages of 
wound healing. Among medicinal plants, the root 
of Curcuma longa L, a species widely used in folk 
medicine, contains pharmacological properties that 
can be applicable in wound healing. This plant, also 
known as curcuma, earth saffron, Indian saffron, 
turmeric, or yellow ginger, has three main curcuminoids 
in its composition: curcumin, desmethoxycurcumin, 
and bisdemethoxycurcumin7,8. Curcumin is the 
most active compound, and studies have shown 
that phenols and methoxy groups are responsible 
for its biological properties9,10. The medicinal use 
of curcuma, both topical and systemic, is based on 
its anti-inflammatory, anti-microbial, antimutagenic, 
anticancer, and antioxidant properties11,12.
Despite the important biological effects, curcumin 
has low bioavailability due to its high metabolism rate 
and poor absorption13. One of the methods used to 
overcome this limitation and ensure the effectiveness 
of its biological properties is to associate curcuma 
extracts with mucoadhesive drug delivery systems. 
These systems have the ability to adhere to the surface 
of epithelial cells or mucus layer, thereby prolonging 
the contact of the drug with the absorption/action 
site, increasing the local or systemic bioavailability 
of the drug14. Different studies have shown that the 
association of drugs to mucoadhesive compounds 
increases its bioavailability15,16. The beneficial effect of 
a mucoadhesive formulation with Curcuma longa L. 
(MFC) has been demonstrated in intestinal and oral 
mucositis17,18. Yet, the effect of MFC on the healing 
of conventional oral ulcers, which are extremely 
recurrent in clinical practice, remains completely 
unexplored. Experimental research carried out with 
Wistar rats is an efficient method to determine the 
efficacy of new extracts in accelerating wound healing. 
Therefore, the aim of this study was to evaluate the 
clinical and histopathological effect of a MFC in oral 
ulcers on Wistar rats.
METHODS
The present study was approved by the Ethics 
Committee on the Use of Animals of the Porto Alegre 
Clinics Hospital, Brazil, under process number 
14-0572. The experimental protocol followed the 
ethics principles in animal experiments, based on 
Law 11.794 of October 8, 2008 and the Brazilian 
Guideline for the Care and Use of Animals for 
Scientific and Educational Purposes of the National 
Council for Animal Experimentation Control.
Design
This was a controlled and blind experiment.
MFC preparation
The extract was prepared at the Laboratory 
of Nanosystems and Drug Delivery Devices 
(NanoSYS), School of Pharmacy, Federal University 
of Goiás (Goiânia, GO, Brazil). A commercial 
Curcuma longa L. extract was acquired from 
Gamma Comércio Importação & Exportação LTDA 
(São Paulo, Brazil), comprising of 96.4% (m/m) 
curcuminoids (curcumin, desmethoxycurcumin, and 
bisdesmethoxycurcumin). Transcutol HP® (diethylene 
glycol monoethyl ether) was generously donated by 
Gattefossé (Lyon, France). Propylene glycol and 
polyethylene glycol were obtained from Labsynt 
(Sao Paulo, Brazil). Poloxamer 407 and Soluplus® 
were obtained from Basf (Ludwigshafen, Germany). 
The mucoadhesive component (poloxamer 407, 
15%, w/v) was dispersed in an organic phase including 
a mixture of polyethylene glycol 400 (PEG 400) and 
propylene glycol, and kept under continuous magnetic 
stirring at 65°C. Next, the curcuminoids were added 
to the mixture and a final concentration of 20 mg/
mL was obtained. Besides, an aqueous fraction was 
prepared by adding Transcutol HP®, Soluplus®, and 
two antioxidants (sodium metabisulfite and sodium 
bisulfite) to purified water under constant stirring. 
Then, the aqueous fraction was heated to 65°C and 
poured into the organic phase. The resulting mixture 
was maintained under continuous stirring for an 
additional 30 min. The pH was adjusted to 6.5 using 
citric acid solution (0.1 M). The curcuminoid content 
in the mucoadhesive formulation was determined 
spectrophotometrically (λ=425 nm). The curcuminoids 
content was 102% of the expected theoretical value. 
A blank formulation (placebo) was prepared as 
described above by substituting the curcumin for an 
equal mass of PEG 400. The placebo formulation 
was also evaluated by spectrophotometric analysis, 
and its constituents showed no interference. The 
formulations were stored in amber flasks at room 
temperature until use.
Animals
The sample size calculation, considering wound 
closure as primary outcome, was based on studies using 
a similar methodology19,20 with a number of 6 animals 
per group per day of euthanasia. Seventy-two male 
rats (Rattus norvegicus albinus, Rodentia, Mammalia, 
Wistar strain) weighing between 270 and 370 g were 
used. The animals were housed individually in plastic 
boxes (40×30×16 cm), with standard chow and water 
ad libitum, at 22±2°C and a light/dark cycle of 12 hours. 
The animals were divided into 3 experimental groups 
(n = 24 per group): Control Group (CG) – untreated 
animals; Placebo Group (PG) – topical use of neutral 
mucoadhesive formulation (no active substance); 
Curcuma longa L. Group (CLG) – topical use of MFC.
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Experimental model
The animals were weighed and anesthetized with 
general anesthetics injected intraperitoneally using 
a mixture of 50 mg/kg of ketamine and 5 mg/kg of 
xylazine, and 1-2% isoflurane was used to achieve 
general anesthesia. Subsequently, ulcers were created 
in the center of the dorsal surface of the tongue of 
each animal using a punch instrument with a diameter 
of 0.3 mm and a height of 0.2 m. The base of the 
ulcer was incised with a scalpel blade #15, creating a 
0.3-mm diameter surgical wound with well delimited 
and regular edges. For pain control, Tramadol 5 mg/
kg was injected intraperitoneally once every 12 hours 
for 2 days. PG and CLG animals received two daily 
applications of neutral mucoadhesive formula and 
MFC, respectively. The amount was determined using a 
0.5-g measuring spoon and the products were applied 
with a flexible rod completely covering the wound, 
under anesthesia with inhaled isoflurane. The animals 
of the CG group were handled daily similarly to the 
other groups, without receiving treatment. Six animals 
of each group were euthanized at 3, 5, 10, and 
14 days under isoflurane anesthesia. The measurement 
of ulcers was then performed, and the wound areas 
were surgically removed and fixed in 10% buffered 
formalin solution and paraffin-embedded using routine 
histopathological procedures.
Clinical Study
The animals were weighed at the beginning of 
the study and before being euthanized. At the end of 
the study, the wounds were photographed and the 
wound area was calculated in pixels using the ImageJ 
1.48v software (National Institutes of Health, USA) 
and then converted to mm² using a reference scale. 
The percentage of wound healing was calculated 
using the formula: [(initial area – final area) / (initial 
area)] × 10021.
Histopathological Study
Serial histological sections were obtained at a 
thickness of 4 μm, stained with hematoxylin-eosin, 
and observed under an optical microscope. Initially, 
a descriptive analysis of each experimental time 
was performed comparing the groups. Next, a semi-
quantitative analysis was performed using scores. 
The criteria described by Sinha and Gallaher22 (2003) 
were used, which scores the level of re-epithelization: 
grade 0 - at the edge of the wound; grade 1 - covering 
less than half of the wound; grade 2 - covering more 
than half of the wound; grade 3 - covering completely 
the wound with irregular thickness; grade 4 - covering 
completely the wound with a normal thickness. 
The degree of inflammation was evaluated as 
described by Kumar, Cotran and Robbins23 (2003): 
grade 1 - acute inflammation (pyogenic membrane); 
grade 2 - predominance of acute diffuse inflammation; 
grade 3 - predominance of chronic inflammatory 
process (proliferating fibroblasts); grade 4 - resolution 
and healing (reduction or disappearance of chronic 
inflammation despite the persistence of some 
inflammatory cells). Two pathologists blind to the 
experimental groups analyzed the sections and 
reached a consensus.
Statistical analysis
The data are reported as means and standard 
deviations. SPSS software version 19.0 was used for 
statistical analysis. The unit of analysis was a single 
animal. Groups, evaluation times, and the interaction 
between group and evaluation time were compared 
by Kruskal-Wallis test or one-way ANOVA. The level 
of significance was set at 5% (p<0.05).
RESULTS
For all analyses, a total number of 6 animals 
were included per group per day of evaluation. No 
adverse effect was observed during the experimental 
procedures.
Body weight results
All groups showed a slight weight loss at day 3 
followed by gradual weight gain up to day 14. No 
significant weight difference was observed between 
groups over the experimental period (Figure 1).
Figure 1: Body weight of animals during the study according 
to treatment groups.
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Clinical Analysis
 A significant difference between groups was found 
for ulcer areas in the three experimental groups on 
days 3 and 5 (Figure 2A). On day 3, CLG presented 
a smaller ulcer area when compared to CG (p <0.01) 
and PG (p <0.001) (Figure 2B and C). Moreover, the 
PG animals presented a larger area when compared 
to the CG (p <0.01). On day 5, there was a reduction of 
the wound in all experimental groups, however, CLG 
presented a smaller wound when compared to PG 
(p <0.0001) and CG (p <0.001). The PG animals showed 
a larger wound than the CG (p <0.001) (Figure 2 D 
and E). On days 10 and 14 there was no difference 
between the groups and all showed wound closure.
Figure 2: A: Healing pattern of oral mucosa wounds according to experimental groups over time; B: On day 3, there was 
a reduction of the wound area in the CLG compared to CG and PG (**p <0.01, ***p <0.001); C: Representative images 
of ulcers in the three groups on day 3; D: On day 5, there was a reduction of the CLG wound area compared to CG and 
PG (***p <0.001, ****p <0.0001); E: Representative images of ulcers in the three groups on day 5.
Descriptive histopathological analysis
On day 3, all groups presented initial healing 
process exhibiting few areas covered by epithelium 
and predominance of exposed connective tissue. 
Acute inflammatory infiltrate (polymorphonuclear 
cells) was observed and at the bottom of the wound 
there was some evidence of collagen fiber deposition 
and angiogenesis.
On day 5, a better repair pattern was observed 
in CLG group with re-epithelialization covering 
completely the wound in most samples associated 
with a chronic inflammatory process. Fibroplasia, 
angiogenesis, and replacement of acute inflammatory 
cells by mononuclear inflammatory cells, mostly 
lymphocytes, were observed in the CLG group. In PG 
and CG, the new epithelial lining was not complete 
and the connective tissue exhibited a more acute 
inflammatory infiltrate compared to CLG (Figure 3).
Figure 3: Microscopic appearance of oral mucosa ulcer 
repair in the three experimental groups on day 5, showing 
the new epithelial pattern (HE, 100x) and inflammatory 
infiltrate (HE, 400x). In CLG, the wound is completely 
covered by epithelial lining and the connective tissue has 
a higher deposition of fibers and a lower level of chronic 
inflammation compared to the other groups.
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On days 10 and 14, all groups showed a similar 
pattern, microscopically. Full coverage of the wound 
with stratified squamous epithelium, reduction of the 
chronic inflammatory process, and organization of 
collagen fibers in the underlying connective tissue 
were observed.
Re-epithelialization degree
CLG animals presented a higher level of re-
epithelialization when compared to CG (p <0.001) 
and PG (p <0.001) on day 5. On days 10 and 14 all 
groups showed complete wound closure (Figure 4A 
and B).
Figure 4: A: Degree of ulcer re-epithelialization in the 
different time-points; B: Re-epithelialization score analysis 
on day 5 showing that CLG presented significantly higher 
scores than CG and PG (****p <0.0001).
Inflammatory degree
On day 5, CLG presented a better resolution of 
the inflammatory process compared to CG (p <0.05) 
and PG (p <0.05) (Figure 5A and B), evidenced 
by a chronic inflammatory process and increased 
angiogenesis and collagen fiber deposition. On days 
10 and 14 there was no difference between groups.
Figure 5: A: Degree of inflammation in the different time-
points; B: Analysis of inflammation on day 5 showing that 
CLG presented a better resolution of the inflammatory 
process (*p <0.05).
DISCUSSION
Oral ulcers are commonly symptomatic and may 
interfere with the patient’s well-being. In the last 
decades, numerous studies have been developed to 
search for effective therapies for the management of 
these lesions, mainly involving the use of analgesics, 
anesthetics, antiseptics, and steroidal and nonsteroidal 
anti-inflammatory drugs2,24. The use of phytotherapeutics 
is a very promising treatment strategy, since these 
compounds have few or no adverse effect and drug 
interactions25,26. Our group has been studying the 
role of different natural compounds in oral lesions 
repair2,20,24,27, and herein we evaluated the topical 
action of MFC in the repair of oral ulcers. Our main 
results demonstrated that MFC accelerated the tissue 
repair process, with a faster re-epithelialization and 
modulation of the inflammatory process.
Curcuma longa L. is a well-known species in folk 
medicine due to its numerous biological activities, 
such as antioxidant, antimicrobial, curative, and anti-
inflammatory8,17,28. An important aspect of curcumin 
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is its safety. The curcuminoids of Curcuma longa L. 
have a good safety profile in humans (12 g/day) and 
in animals (100 mg/kg per day), and are non-toxic 
even at high doses29,30. Our study did not directly 
assess the safety of this compound, but the analysis 
of body weight of the animals indirectly showed that 
MFC was not toxic to the animals. In addition, the 
animals of the 3 groups showed similar behavior 
throughout the study. After some weight loss in the first 
few days of the experiment, probably associated with 
the surgically created wound, the animals resumed 
normal feeding and weight gain.
Our results showed that CLG presented a smaller 
wound on days 3 and 5 compared to the other groups, 
demonstrating its capacity to accelerate oral wound 
healing. Curcumin also exhibited healing proprieties 
in other conditions, such as intestinal mucositis17. 
We recently demonstrated that MFC accelerated oral 
mucositis healing in an animal model18. Likewise, 
Patil and collaborators31 (2015) demonstrated that a 
solution containing 0.004% curcumin was effective 
in healing oral mucositis in patients submitted to 
radio- or chemotherapy. Herein, we evaluated for the 
first time the healing effect of MFC in conventional 
oral ulcers, which have a different pathophysiology 
compared to oral mucositis. Moreover, oral ulcers, 
such as traumatic ulcers and recurrent aphthous 
stomatitis, are extremely common in our population. 
Therefore, we consider that the findings of the 
present study are relevant and indicate that this 
herbal medicine has potential as treatment of such 
oral lesions. Moreover, the association of Curcuma 
longa L. extract with a mucoadhesive formulation 
enhances the adhesion of the drug to the mucosa, 
probably increasing the drug’s bioavailability and 
consequently its beneficial effects. The healing capacity 
of MFC has been previously demonstrated by our 
group in intestinal and oral mucositis17,18. Therefore, 
we believe that this strategy is highly efficient for 
a greater adhesion of the active compound. In 
addition, the increased retention decreases the risk 
of the patient swallowing the compound, preventing 
possible systemic adverse effects.
The histopathological findings observed in the 
present study corroborate our clinical findings. The 
improved repair pattern of the CLG group occurred due 
to the acceleration of the re-epithelialization process 
associated with the modulation of the inflammatory 
process in the connective tissue. Wound healing is a 
complex physiological process divided into three main 
overlapping stages: inflammation, cell proliferation, 
and remodeling phases32. First, the injury triggers 
inflammation leading to hemostasis and clot formation 
followed by an acute tissue response. After, chronic 
inflammatory events replace the acute scenario, 
with fibroplasia and neovascularization along with 
re-epithelization. In the final stage, formation of new 
extracellular matrix and tissue remodeling occur. The 
analysis of the inflammatory cells allows determining 
the stage of tissue repair. In the present study, the 
treatment of oral ulcers with MFC led to a faster 
resolution of the inflammatory process compared to 
the other groups. On day 5, the wounds treated with 
MFC had less acute inflammation, increased chronic 
inflammatory process evidenced by the presence of 
newly formed blood vessels, deposition of collagen 
fibers, and a higher level of re-epithelialization, 
indicating better tissue repair. In other words, 
the curcuminoids present in MFC controlled the 
inflammatory response, preventing its exacerbation 
and stimulating an earlier resolution. As demonstrated 
by other studies, curcuminoids act by modulating 
several transcription factors, especially the nuclear 
factor kappa B (NF-kB) and cycloxigenase-2 (COX-2)7. 
In addition, the anti-inflammatory effect of curcumin 
is explained by its ability to reduce myeloperoxidase 
activity, which is related to neutrophil infiltration17.
The re-epithelialization process occurs most 
clearly in the proliferative phase of repair and is 
important for the formation of the epithelial barrier 
that allows tissue homeostasis to be restored33,34. 
Thus, our results indicate that the use of MFC 
promotes re-epithelialization at an earlier stage, 
accelerating wound repair. Likewise, the study 
by dos Santos Filho et al.17. (2015) demonstrated 
that a curcumin-containing compound stimulated 
intestinal epithelial proliferation, evidenced by 
the increased expression of the Ki67 proliferation 
marker. The compound was also able to decrease 
the expression of the Bax-2 apoptosis marker. 
Molecular analysis indicates that curcumin acts 
by activating transcription factors, growth factors 
and their receptors, modulating the synthesis of 
cytokines, and thus regulating genes involved in 
cell proliferation and apoptosis8.
Despite our promising results, extrapolating the 
present findings to wound treatment in humans is not 
advised, as animal models may not always adequately 
mimic human pathophysiology35. However, our 
previous experience with wound healing suggests that 
the Wistar rat model provides translational evidence 
that can be successfully reproduced in humans36,37. 
Therefore, we believe MFC is a promising treatment 
strategy for oral wounds in humans.
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CONCLUSION
We demonstrated that the mucoadhesive formulation 
containing Curcuma L. extract accelerated the 
repair of oral ulcers by modulating the inflammatory 
response and stimulating re-epithelialization in an 
animal model. Further studies, especially randomized 
clinical trials with humans, are needed to confirm 
these preliminary findings.
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